|
|
|
Massachusetts Real Estate Attorney
Law Firm Press |
2014/11/11 14:54
|
For more than 30 years, Attorney Alan H. Segal has been lending legal
expertise to the Greater Boston Massachusetts area from his Needham,
Massachusetts Law Office. With great attentiveness, Alan and his
associates have given legal consultation in business law, estate
planning, and Massachusetts real estate law.
You can find Alan on the radio, cable, and local television sharing
his ideas about current legal news. Navigating your way through the
legal system can be a confusing and difficult task. He and his staff
know that and want to be there for you as "YOUR LAWYER".
To visit the Law Office of Alan H. Segal, head to the intersection of
Highland Ave and Route 128/95 on the Newton / Needham border, next to
Staples.
Attorney Alan H. Segal has been known as a renowned Massachusetts real
estate attorney for over 30 years. Sellers, buyers, and lenders of
Massachusetts real estate property are all represented by his
practice.
It is prudent to seek the guidance of a real estate agent like Alan to
help with all real estate home buying in Massachusetts, as all such
transactions have legal issues and tax consequences.
If you need an experienced Massachusetts real estate attorney contact
us today for a free and confidential consultation!
If you require an experienced real estate attorney in Massachusetts,
contact us today! The consultation is confidential and free!
|
|
|
|
|
|
Court: No blanket exemption for police dashcams
Law Firm Press |
2014/06/13 12:13
|
The state Supreme Court has ruled that state dashboard cameras can't be withheld from public disclosure unless they relate to pending litigation.
Five of the high court's members said Thursday that the Seattle Police Department wrongly used a state statute as a blanket exemption to the state's public records act when it denied providing dashboard camera videos to a reporter with KOMO-TV. Their ruling overturns a 2012 King County Superior Court judge's ruling that said the department could withhold the videos for three years.
The majority awarded KOMO attorney fees and sent the case back to the lower court.
Four justices argued that the statute was clear that that the recordings should not be released to the public until completion of any criminal or civil litigation. |
|
|
|
|
|
Top court rejects bail plea of Indian tycoon
Law Firm Press |
2014/06/06 15:01
|
India's Supreme Court Wednesday rejected an appeal by an Indian tycoon accused of a multibillion dollar fraud to be released from jail and allowed house arrest.
Subrata Roy, head of the Sahara India conglomerate, has been jailed since March 4 on charges that his company failed to return billions of dollars to investors. Bail was earlier set at $1.68 billion and the company has struggled to raise the funds.
India's securities regulator has accused Sahara India of raising nearly 200 billion rupees ($3.2 billion) through bonds that were later found to be illegal.
Sahara is well known throughout India because it sponsors the Indian cricket team. The company also sponsors the Indian hockey team and owns a stake in Formula One racing team, Force India.
The company has interests in microfinance, media and entertainment, tourism, health care and real estate, including New York's landmark Plaza Hotel and London's Grosvenor House.
The court Wednesday allowed the Sahara group to sell properties in nine Indian cities after the company said it had not succeeded in raising the $1.68 billion needed to obtain bail for Roy.
The court had earlier rejected a proposal by the company to pay bail in instalments. |
|
|
|
|
|
Court declines to block drug ruling in patent case
Law Firm Press |
2014/04/21 14:22
|
Supreme Court Chief Justice John Roberts on Friday declined to temporarily block a lower court ruling that opens the world's best-selling multiple sclerosis drug to competition from generic rivals next month.
The decision is a victory for rivals challenging the patents of Israel-based Teva Pharmaceutical Industries Ltd., maker of the drug Copaxone.
Teva claims the U.S. Court of Appeals for the Federal Circuit wrongly overturned five of its patents for the drug. That ruling allows rivals Mylan Inc., Momenta Pharmaceuticals Inc. and Sandoz, Inc., to start selling cheaper generic versions in May instead of September 2015.
The Supreme Court has agreed to consider the case, but arguments won't take place until its new term begins in October and it could be next year before a decision is reached. Teva said it would suffer irreparable harm if the appeals court decision was not postponed. Copaxone brought the company $3.2 billion in U.S. sales last year.
In a one-page ruling, Roberts said he was not convinced Teva would suffer such harm. If Teva ultimately prevails in the case, Roberts said, the company would be able to recover damages from the generic rivals for past patent infringement. He acknowledged that Teva has "a fair prospect" of ultimately winning the case at the high court.
Roberts oversees emergency appeals from the U.S. Court of Appeals for the Federal Circuit, which hears appeals in patent cases. |
|
|
|
|